当前位置:产品中心>单抗/多抗

Anti-Human TROP2 Reference Antibody|抗人TROP2参考抗体(靶标:人滋养层细胞表面抗原2)

货号:RB9T37015429
  • 价格:面议
  • 点击数:555
  

产品介绍

产品参数

形态Liquid
宿主种属Humanized
克隆性Monoclonal
抗体亚型IgG1-kappa
纯度>98% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度5.13mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标Pancreatic carcinoma marker protein GA733-1, Tumor-associated calcium signal transducer 2, M1S1, TROP2, TACSTD2, Cell surface glycoprotein Trop-2, GA733-1, Membrane component chromosome 1 surface mark
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号P09758
背景信息Sacituzumab is a humanized IgG1 monoclonal antibody targeting Trophoblast cell surface antigen 2 (TROP2). Sacituzumab demonstrates a lack of antitumor effects alone and does not inhibit the function of TROP-2 during tumor metastasis, binding to the linear epitopes of TROP-2 protein. Sacituzumab is used for the synthesis of antibody-drug conjugates (ADC) drugs. Antibody-drug conjugates with sacituzumab (sacituzumab govitecan)targeting TROP-2 have been approved for the field of triple-negative breast cancer.<br>• RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models., PMID:27582525<br/>• Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics., PMID:19088204<br/>
别名IMMU-132, hRS7-SN-38, hRS7-SN-38-ADC, hRS7-[CL-SN-38], 1796566-95-4
备注For research use only. Not suitable for clinical or therapeutic use.